EPISODE · Nov 10, 2022 · 32 MIN
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
from The Readout Loud · host STAT
STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.
Embed this episode
NOW PLAYING
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.